Target intelligence / Profile preview

Extracellular matrix protein in the intervertebral disc (IVD ECM)

Target
IVD ECM
Molecular classification
Structural protein, Proteoglycan, Glycoprotein, Collagen
01

Overview

The extracellular matrix (ECM) of the intervertebral disc is a specialized, highly hydrated scaffold that provides the spine with structural integrity and the ability to withstand mechanical loads. It is primarily composed of a dense network of type II collagen fibers, which provide tensile strength, and large proteoglycans like aggrecan, which create osmotic pressure to maintain hydration (Roughley, P. J., 2004, Spine). In degenerative disc disease, the homeostatic balance is lost as catabolic enzymes, including matrix metalloproteinases (MMPs) and ADAMTS, degrade these essential proteins, leading to disc height loss and pain (Urban, J. P., & Roberts, S., 2003, Lancet). Therapeutic strategies focus on regenerating the ECM by using growth factors such as Growth Differentiation Factor 5 (GDF-5) or Bone Morphogenetic Protein 7 (BMP-7) to stimulate resident cells to produce new matrix components (Sivan, S. S., et al., 2014, Arthritis Research & Therapy). Additionally, peptides like Link N are being explored for their potential to upregulate the synthesis of collagen and aggrecan. Successful restoration of the ECM is considered a primary goal for biological therapies aiming to treat chronic low back pain and reverse disc degeneration.

Other names
Intervertebral disc extracellular matrixIVD matrixDisc ECMNucleus pulposus matrixAnnulus fibrosus matrix
02

Mechanism of action

Promotion of proteoglycan and collagen synthesis via anabolic signaling and inhibition of proteolytic degradation by MMPs and ADAMTS.

03

Biological functions

Mechanical load distributionStructural integrityCell-matrix signalingHydration maintenanceTissue resilience
04

Disease associations

Intervertebral disc degenerationLow back painHerniated discSpondylosisDegenerative disc disease
05

Safety considerations

Ectopic bone formationAvascularity-related nutrient limitationsRisk of endplate calcificationShort half-life of growth factorsPotential for inflammatory response to delivery vehicles
06

Interacting drugs

Growth differentiation factor 5

4 more in the full profile.

07

Biomarkers

C-terminal telopeptide of type II collagen (CTX-II)Aggrecan-derived fragments (ARGS)Carboxy-terminal propeptide of type II collagen (CPII)Keratan sulfate

Beyond the preview

Go deeper on Extracellular matrix protein in the intervertebral disc (IVD ECM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular matrix protein in the intervertebral disc (IVD ECM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call